John G. Lemkey, Officer, Chief Executive Officer, 10% Owner, Chief Financial Officer at Odonate Therapeutics, Inc. (ODT), bought 59,530 shares at $14.69 ($919K) on 2018-10-24, disclosed to the SEC on 2018-10-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.42 | 6,687 | $103K | 11.2% |
| 2 | $15.42 | 6,687 | $103K | 11.2% |
| 3 | $15.45 | 10,000 | $155K | 16.8% |
| 4 | $14.69 | 10,000 | $147K | 16.0% |
| 5 | $15.61 | 3,313 | $52K | 5.6% |
| 6 | $15.61 | 3,313 |
| $52K |
| 5.6% |
| 7 | $15.78 | 9,765 | $154K | 16.8% |
| 8 | $15.78 | 9,765 | $154K | 16.8% |
| Total | $15.44 avg | 59,530 | $919K | 100% |
| Filing → |
| ODT | BUY | 2019-03-11 | $4.7M | — | Filing → |
| ODT | BUY | 2018-12-26 | $756K | — | Filing → |
| ODT | BUY | 2018-12-18 | $848K | — | Filing → |